Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
52.3 USD | +4.52% | -7.12% | +28.29% |
Jun. 07 | Structure Therapeutics Closes $547.4 Million Offering | MT |
Jun. 07 | BMO Capital Adjusts Price Target on Structure Therapeutics to $100 From $83, Maintains Outperform Rating | MT |
Business Summary
Number of employees: 111
Managers
Managers | Title | Age | Since |
---|---|---|---|
Raymond Stevens
FOU | Founder | 60 | 19-01-31 |
Jun Yoon
DFI | Director of Finance/CFO | 46 | 19-01-31 |
Ying Li Ma
CTO | Chief Tech/Sci/R&D Officer | 50 | 22-07-31 |
Xi Chen Lin
CTO | Chief Tech/Sci/R&D Officer | 50 | 19-06-30 |
Mark Bach
CTO | Chief Tech/Sci/R&D Officer | 67 | 21-05-31 |
Lani Ibarra
CTO | Chief Tech/Sci/R&D Officer | - | - |
Tony Peng
LAW | General Counsel | - | - |
Karen S. Wright
AUD | Comptroller/Controller/Auditor | 69 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sharon Tetlow
BRD | Director/Board Member | 64 | 22-03-28 |
Ted Love
BRD | Director/Board Member | 65 | 23-08-02 |
Eric Dobmeier
BRD | Director/Board Member | 55 | 22-11-30 |
Daniel Welch
CHM | Chairman | 66 | 22-01-18 |
Ramy Farid
BRD | Director/Board Member | 59 | 19-03-31 |
Raymond Stevens
FOU | Founder | 60 | 19-01-31 |
Jun Yoon
DFI | Director of Finance/CFO | 46 | 19-01-31 |
Director/Board Member | 64 | 22-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 2,161 | 0 | 0 | 76.06 % |
Stock B | 0 | 32,857 | 0 | 0 | |
Stock C | 1 | 139,794,124 | 106,321,015 ( 76.06 %) | 0 | |
Stock D | 0 | 12,800 | 0 | 0 | |
Stock E | 0 | 19,200 | 0 | 0 |
Company contact information
Structure Therapeutics, Inc.
601 Gateway Boulevard Suite 900
94080, South San Francisco
+
http://www.structuretx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.77% | 2.33B | |
+18.34% | 124B | |
+15.06% | 109B | |
-6.39% | 23.84B | |
+1.02% | 22.42B | |
-14.64% | 17.5B | |
-41.64% | 16.43B | |
-12.07% | 16.61B | |
+1.05% | 13.4B | |
+25.87% | 11.47B |
- Stock Market
- Equities
- GPCR Stock
- Company Structure Therapeutics Inc.